Lon Weiner, MD
Orthopedic Surgery · New York, NYNPI 1043310394
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $481,682 of the $622,261 with a category attached, or 77.4%. 14 manufacturers reported payments, led by Medartis Inc. at 52.7% of the total. Reporting peaked in 2022 at $268,344 and has fallen 98.9% since, to $2,917 in 2025. Among orthopedic surgery clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 111 payments — averaging $5605.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medartis Inc.$328K
- Nextremity Solutions Inc.$273K
- Zimmer Biomet$20K
- Globus Medical$417
- Johnson & Johnson$134
- Terumo BCT, Inc.$134
- plus $479 from 8 others
What the payments were for
- Royalty or licence$481,68277%
- Consulting fees$131,99521%
- Travel & lodging$5,3611%
- Food & beverage$2,9670%
- Gifts$2560%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medartis Inc. | 24 | $327,887 |
| Nextremity Solutions Inc. | 40 | $273,255 |
| Zimmer Biomet | 22 | $19,954 |
| Globus Medical | 7 | $417 |
| Johnson & Johnson | 3 | $134 |
| Terumo BCT, Inc. | 1 | $134 |
| Sanara Medtech Inc. | 1 | $103 |
| Stryker | 2 | $96 |
| Baxter Healthcare | 4 | $93 |
| Arteriocyte Medical Systems, Inc. | 2 | $87 |
| Acell, Inc. | 2 | $41 |
| Bioventus LLC | 1 | $28 |
| Smith+Nephew | 1 | $17 |
| Ferring Pharmaceuticals Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- APTUS$327,858
- Ace Fischer Frame$14,867
- Foot & Ankle-None$3,750
- ACE-FISCHER LARGE FOOT FRAME$1,195
- Bone Marrow Aspirate Concentrate System$134
- CellerateRx$103
How this compares
$622,261 in reported general payments places this provider in the 95th percentile of 91 orthopedic surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Potassium | 14 | $233 |
| Celecoxib | 15 | $199 |
| Meloxicam | 25 | $59 |
Paid to pharmacies, not to this prescriber.
Other orthopedic surgery in New York
- Baron LonnerNew York$2.1M
- James GladstoneNew York$260K
- Thomas WickiewiczNew York$201K
- David EssigNew York$123K
- Stephen ObrienNew York$17K
- James SloverNew York$13K
- Tyler LucasNew York$7K
- Afshin RaziNew York$3K
- Benjamin RosenstadtNew York$2K
- Peter FrelinghuysenNew York$266
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.